NURS 5434 Family III Final Exam:
FNP Family Nurse Practitioner III
Test Bank Questions And Well
Graded Solutions With Rationales
Updated 2026 2027
Ace your NURS 5434 Family Nurse Practitioner III (Family III) Final Exam with
this comprehensive 2026 study guide and verified test bank. Features highly
structured, high-yield multiple-choice questions with precise diagnostic
rationales, detailed ASCII clinical flows, and USPSTF comparison tables. Master
complex pediatric dyslipidemia screening, adult hypertension step-therapy, GINA
asthma management, diabetic pharmacology, and neurological differential
diagnostics. Perfect for FNP students.
1|Page
, Final Exam Comprehensive Practice Blueprint — Part 1 (Questions 1–100)
1. A 45-year-old male presents for a routine physical. He has no significant medical
history. According to the United States Preventive Services Task Force (USPSTF)
guidelines, which screening intervention carries a Grade A or B recommendation for
this patient?
A) Routine screening for abdominal aortic aneurysm via ultrasound
B) Screening for colorectal cancer using a highly sensitive fecal immunochemical
test (FIT)
C) Routine screening for prostate cancer using prostate-specific antigen (PSA)
D) Screening for lung cancer with low-dose computed tomography (LDCT)
B) Screening for colorectal cancer using a highly sensitive fecal
immunochemical test (FIT)
Rationale: The USPSTF recommends colorectal cancer screening for all adults aged
45 to 75 years (Grade B recommendation). Routine screening for abdominal aortic
aneurysm is only recommended for men aged 65 to 75 who have ever smoked.
Routine PSA screening carries a Grade C recommendation, and lung cancer
screening is reserved for older individuals with a significant smoking history.
2. A 24-year-old female presents to the clinic for her wellness examination. She asks
how frequently she needs to undergo cervical cancer screening with a Papanicolaou
(Pap) smear. She has no history of abnormal results.
A) Annually
B) Every 2 years
C) Every 3 years
D) Every 5 years
C) Every 3 years
Rationale: For women aged 21 to 29 years, the USPSTF recommends cervical
cancer screening with cervical cytology alone every 3 years. Screening with high-risk
human papillomavirus (hrHPV) testing alone or in combination with cytology
(cotesting) every 5 years is an option starting at age 30.
3. During a routine wellness check, a 52-year-old female patient asks about the
benefits of learning breast self-examination (BSE) to detect breast cancer early.
According to the USPSTF guidelines, how should the Family Nurse Practitioner
advise this patient?
A) BSE should be performed weekly immediately following the menstrual cycle.
B) BSE should be performed monthly to reduce breast cancer mortality.
C) BSE is classified as secondary prevention but is explicitly not recommended by
the USPSTF due to lack of net benefit.
D) BSE should be combined with annual clinical breast examinations starting at age
40.
C) BSE is classified as secondary prevention but is explicitly not
recommended by the USPSTF due to lack of net benefit.
Rationale: The USPSTF recommends against teaching breast self-examination
(Grade D recommendation) because evidence shows it does not reduce breast
cancer mortality but does significantly increase rates of unnecessary imaging and
benign breast biopsies.
2|Page
,4. A 10-year-old male child is brought to the clinic for a routine pediatric maintenance
visit. His mother has a history of high cholesterol, but there is no family history of
premature premature cardiovascular disease. What is the correct approach to lipid
screening for this child?
A) Defer lipid screening until the patient reaches 17 years of age.
B) Perform a universal lipid screening at this visit using a fasting or non-fasting lipid
panel.
C) Obtain a fasting lipid panel only if his body mass index is above the 95th
percentile.
D) Order a lipid panel only if a grandparent had a myocardial infarction before age
55.
B) Perform a universal lipid screening at this visit using a fasting or non-
fasting lipid panel.
Rationale: Guidelines from the AAP and NHLBI recommend universal screening for
dyslipidemia in children once between the ages of 9 and 11 years, and again
between the ages of 17 and 21 years, regardless of family history or risk factors.
5. A 9-year-old female is diagnosed with pediatric hypertension after three separate
elevated blood pressure readings that plot above the 95th percentile for her age,
sex, and height. Which diagnostic test is NOT routinely recommended as part of the
initial standard workup for primary pediatric hypertension?
A) Fasting lipid panel and fasting blood glucose
B) Blood urea nitrogen (BUN) and serum creatinine
C) Renal ultrasound
D) Electrocardiogram (EKG)
D) Electrocardiogram (EKG)
Rationale: The initial evaluation for pediatric hypertension focuses on identifying
secondary causes (renal function, renal ultrasound) and concurrent metabolic risks
(lipids, glucose). An EKG is not routinely recommended for evaluating target organ
damage in children; an echocardiogram is the preferred imaging modality if target
organ damage is suspected.
6. Figure: Pediatric Hypertension Treatment Titration Pathway
[Diagnose HTN] ➔ [Lifestyle Modification] ➔ [Initiate Single Low-Dose
Agent]
│
[Refer to Cardiology] ◄── [Stage II HTN Persists] ◄── [Titrate Agent to
Max Dose]
A 10-year-old male with persistent Stage I hypertension has failed to achieve blood
pressure control after 6 months of structured lifestyle modifications. The clinician
decides to initiate pharmacotherapy. Which of the following describes the correct
initial management strategy?
A) Start a combination of an ACE inhibitor and a thiazide diuretic at full therapeutic
doses.
B) Initiate a single approved medication at a low dose and titrate upward before
adding a second agent.
C) Immediately refer the patient to pediatric cardiology before prescribing any
medication.
D) Prescribe clonidine transdermal patch as the first-line choice for pediatric patients.
B) Initiate a single approved medication at a low dose and titrate upward
before adding a second agent.
Rationale: Pharmacologic management of pediatric hypertension begins with
3|Page
, monotherapy using an approved agent (such as an ACE inhibitor, ARB, CCB, or
thiazide diuretic) at the lowest effective dose. The dose is titrated upward until blood
pressure control is achieved or the maximum dose is reached before adding a
second agent.
7. A 54-year-old male with type 2 diabetes mellitus is currently taking metformin 1000
mg twice daily, glipizide 10 mg twice daily, and empagliflozin 25 mg daily. His
hemoglobin A1c remains elevated at 8.9%. The clinician decides to initiate basal
insulin. What modification is most critical to prevent profound hypoglycemia?
A) Discontinue metformin immediately.
B) Reduce or discontinue the sulfonylurea (glipizide) dose.
C) Increase the empagliflozin dose to compensate for the insulin.
D) Double the dose of metformin to maximize insulin sensitivity.
B) Reduce or discontinue the sulfonylurea (glipizide) dose.
Rationale: When introducing basal insulin to a complex regimen containing a insulin
secretagogue like a sulfonylurea (glipizide), the risk of hypoglycemia increases
dramatically. It is critical to reduce or discontinue the sulfonylurea to prevent severe
hypoglycemic events.
8. A 48-year-old female patient presents to the clinic reporting a persistent, dry, non-
productive cough that began three weeks ago. She was started on lisinopril for
hypertension two months ago. She denies fever, chills, rhinorrhea, or wheezing.
What is the underlying pathophysiological mechanism of this adverse effect?
A) Direct activation of alveolar macrophages by the medication
B) Accumulation of bradykinin and substance P in the respiratory tract
C) Bronchoconstriction mediated by beta-2 receptor blockade
D) Increased pulmonary capillary wedge pressure
B) Accumulation of bradykinin and substance P in the respiratory tract
Rationale: ACE inhibitors prevent the breakdown of bradykinin and substance P,
leading to their accumulation in the respiratory tract, which stimulates superficial
cough receptors. This side effect is not dose-dependent and requires switching to an
ARB.
9. A 62-year-old male patient with a history of hyperlipidemia presents for follow-up.
The clinician decides to initiate moderate-intensity statin therapy. What is the
expected average reduction in low-density lipoprotein cholesterol (LDL-C) with this
intensity of therapy?
A) Less than 30%
B) 30% to 50%
C) 51% to 65%
D) Greater than 65%
B) 30% to 50%
Rationale: By clinical definition, moderate-intensity statin therapy (e.g., Atorvastatin
10–20 mg or Rosuvastatin 5–10 mg) lowers LDL-C by approximately 30% to 50%.
High-intensity statin therapy lowers LDL-C by 50% or more.
10. A 34-year-old female presents with a history of recurrent, throbbing, unilateral
headaches that last between 4 and 72 hours. The headaches are accompanied by
nausea and sensitivity to light and sound. She has experienced 6 distinct episodes
over the past year. What is the first-line abortive pharmacotherapy for this condition,
provided there are no contraindications?
A) Acetaminophen
B) Triptans
4|Page
FNP Family Nurse Practitioner III
Test Bank Questions And Well
Graded Solutions With Rationales
Updated 2026 2027
Ace your NURS 5434 Family Nurse Practitioner III (Family III) Final Exam with
this comprehensive 2026 study guide and verified test bank. Features highly
structured, high-yield multiple-choice questions with precise diagnostic
rationales, detailed ASCII clinical flows, and USPSTF comparison tables. Master
complex pediatric dyslipidemia screening, adult hypertension step-therapy, GINA
asthma management, diabetic pharmacology, and neurological differential
diagnostics. Perfect for FNP students.
1|Page
, Final Exam Comprehensive Practice Blueprint — Part 1 (Questions 1–100)
1. A 45-year-old male presents for a routine physical. He has no significant medical
history. According to the United States Preventive Services Task Force (USPSTF)
guidelines, which screening intervention carries a Grade A or B recommendation for
this patient?
A) Routine screening for abdominal aortic aneurysm via ultrasound
B) Screening for colorectal cancer using a highly sensitive fecal immunochemical
test (FIT)
C) Routine screening for prostate cancer using prostate-specific antigen (PSA)
D) Screening for lung cancer with low-dose computed tomography (LDCT)
B) Screening for colorectal cancer using a highly sensitive fecal
immunochemical test (FIT)
Rationale: The USPSTF recommends colorectal cancer screening for all adults aged
45 to 75 years (Grade B recommendation). Routine screening for abdominal aortic
aneurysm is only recommended for men aged 65 to 75 who have ever smoked.
Routine PSA screening carries a Grade C recommendation, and lung cancer
screening is reserved for older individuals with a significant smoking history.
2. A 24-year-old female presents to the clinic for her wellness examination. She asks
how frequently she needs to undergo cervical cancer screening with a Papanicolaou
(Pap) smear. She has no history of abnormal results.
A) Annually
B) Every 2 years
C) Every 3 years
D) Every 5 years
C) Every 3 years
Rationale: For women aged 21 to 29 years, the USPSTF recommends cervical
cancer screening with cervical cytology alone every 3 years. Screening with high-risk
human papillomavirus (hrHPV) testing alone or in combination with cytology
(cotesting) every 5 years is an option starting at age 30.
3. During a routine wellness check, a 52-year-old female patient asks about the
benefits of learning breast self-examination (BSE) to detect breast cancer early.
According to the USPSTF guidelines, how should the Family Nurse Practitioner
advise this patient?
A) BSE should be performed weekly immediately following the menstrual cycle.
B) BSE should be performed monthly to reduce breast cancer mortality.
C) BSE is classified as secondary prevention but is explicitly not recommended by
the USPSTF due to lack of net benefit.
D) BSE should be combined with annual clinical breast examinations starting at age
40.
C) BSE is classified as secondary prevention but is explicitly not
recommended by the USPSTF due to lack of net benefit.
Rationale: The USPSTF recommends against teaching breast self-examination
(Grade D recommendation) because evidence shows it does not reduce breast
cancer mortality but does significantly increase rates of unnecessary imaging and
benign breast biopsies.
2|Page
,4. A 10-year-old male child is brought to the clinic for a routine pediatric maintenance
visit. His mother has a history of high cholesterol, but there is no family history of
premature premature cardiovascular disease. What is the correct approach to lipid
screening for this child?
A) Defer lipid screening until the patient reaches 17 years of age.
B) Perform a universal lipid screening at this visit using a fasting or non-fasting lipid
panel.
C) Obtain a fasting lipid panel only if his body mass index is above the 95th
percentile.
D) Order a lipid panel only if a grandparent had a myocardial infarction before age
55.
B) Perform a universal lipid screening at this visit using a fasting or non-
fasting lipid panel.
Rationale: Guidelines from the AAP and NHLBI recommend universal screening for
dyslipidemia in children once between the ages of 9 and 11 years, and again
between the ages of 17 and 21 years, regardless of family history or risk factors.
5. A 9-year-old female is diagnosed with pediatric hypertension after three separate
elevated blood pressure readings that plot above the 95th percentile for her age,
sex, and height. Which diagnostic test is NOT routinely recommended as part of the
initial standard workup for primary pediatric hypertension?
A) Fasting lipid panel and fasting blood glucose
B) Blood urea nitrogen (BUN) and serum creatinine
C) Renal ultrasound
D) Electrocardiogram (EKG)
D) Electrocardiogram (EKG)
Rationale: The initial evaluation for pediatric hypertension focuses on identifying
secondary causes (renal function, renal ultrasound) and concurrent metabolic risks
(lipids, glucose). An EKG is not routinely recommended for evaluating target organ
damage in children; an echocardiogram is the preferred imaging modality if target
organ damage is suspected.
6. Figure: Pediatric Hypertension Treatment Titration Pathway
[Diagnose HTN] ➔ [Lifestyle Modification] ➔ [Initiate Single Low-Dose
Agent]
│
[Refer to Cardiology] ◄── [Stage II HTN Persists] ◄── [Titrate Agent to
Max Dose]
A 10-year-old male with persistent Stage I hypertension has failed to achieve blood
pressure control after 6 months of structured lifestyle modifications. The clinician
decides to initiate pharmacotherapy. Which of the following describes the correct
initial management strategy?
A) Start a combination of an ACE inhibitor and a thiazide diuretic at full therapeutic
doses.
B) Initiate a single approved medication at a low dose and titrate upward before
adding a second agent.
C) Immediately refer the patient to pediatric cardiology before prescribing any
medication.
D) Prescribe clonidine transdermal patch as the first-line choice for pediatric patients.
B) Initiate a single approved medication at a low dose and titrate upward
before adding a second agent.
Rationale: Pharmacologic management of pediatric hypertension begins with
3|Page
, monotherapy using an approved agent (such as an ACE inhibitor, ARB, CCB, or
thiazide diuretic) at the lowest effective dose. The dose is titrated upward until blood
pressure control is achieved or the maximum dose is reached before adding a
second agent.
7. A 54-year-old male with type 2 diabetes mellitus is currently taking metformin 1000
mg twice daily, glipizide 10 mg twice daily, and empagliflozin 25 mg daily. His
hemoglobin A1c remains elevated at 8.9%. The clinician decides to initiate basal
insulin. What modification is most critical to prevent profound hypoglycemia?
A) Discontinue metformin immediately.
B) Reduce or discontinue the sulfonylurea (glipizide) dose.
C) Increase the empagliflozin dose to compensate for the insulin.
D) Double the dose of metformin to maximize insulin sensitivity.
B) Reduce or discontinue the sulfonylurea (glipizide) dose.
Rationale: When introducing basal insulin to a complex regimen containing a insulin
secretagogue like a sulfonylurea (glipizide), the risk of hypoglycemia increases
dramatically. It is critical to reduce or discontinue the sulfonylurea to prevent severe
hypoglycemic events.
8. A 48-year-old female patient presents to the clinic reporting a persistent, dry, non-
productive cough that began three weeks ago. She was started on lisinopril for
hypertension two months ago. She denies fever, chills, rhinorrhea, or wheezing.
What is the underlying pathophysiological mechanism of this adverse effect?
A) Direct activation of alveolar macrophages by the medication
B) Accumulation of bradykinin and substance P in the respiratory tract
C) Bronchoconstriction mediated by beta-2 receptor blockade
D) Increased pulmonary capillary wedge pressure
B) Accumulation of bradykinin and substance P in the respiratory tract
Rationale: ACE inhibitors prevent the breakdown of bradykinin and substance P,
leading to their accumulation in the respiratory tract, which stimulates superficial
cough receptors. This side effect is not dose-dependent and requires switching to an
ARB.
9. A 62-year-old male patient with a history of hyperlipidemia presents for follow-up.
The clinician decides to initiate moderate-intensity statin therapy. What is the
expected average reduction in low-density lipoprotein cholesterol (LDL-C) with this
intensity of therapy?
A) Less than 30%
B) 30% to 50%
C) 51% to 65%
D) Greater than 65%
B) 30% to 50%
Rationale: By clinical definition, moderate-intensity statin therapy (e.g., Atorvastatin
10–20 mg or Rosuvastatin 5–10 mg) lowers LDL-C by approximately 30% to 50%.
High-intensity statin therapy lowers LDL-C by 50% or more.
10. A 34-year-old female presents with a history of recurrent, throbbing, unilateral
headaches that last between 4 and 72 hours. The headaches are accompanied by
nausea and sensitivity to light and sound. She has experienced 6 distinct episodes
over the past year. What is the first-line abortive pharmacotherapy for this condition,
provided there are no contraindications?
A) Acetaminophen
B) Triptans
4|Page
